Furthermore, Epac has been shown to mediate cAMP-induced inhibition of DNA damage repair in lung cancer by promoting the degradation of X-ray repair cross-complementing protein 1 (XRCC1) [56]. This evidence concerns the gene RAPGEF3 and lung cancer.